IPP Bureau
AXA in India boosts telemedicine helpline with free specialist teleconsultation feature
By IPP Bureau - March 10, 2022
SAATH is a ‘One AXA’ public health initiative between AXA France Vie, AXA GO Business Operations, and AXA XL
Zydus Lifesciences subsidiary Sentynl acquires BridgeBio’s Nulibry
By IPP Bureau - March 09, 2022
Nulibry is approved by the U.S. Food and Drug Administration (USFDA) to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening paediatric genetic disorder
Alkido Pharma and Cedars-Sinai enter Master Collaboration Agreement
By IPP Bureau - March 09, 2022
Cedars-Sinai Technology Ventures has had 114 patents issued for the fiscal year 2021 and has 511 active technologies under development, as of July 2021
USFDA approves Evoke Spinal Cord Stimulation System
By IPP Bureau - March 09, 2022
Transformative closed-loop technology senses the spinal cord's response to stimulation and instantaneously adjusts therapy to sustain durable, optimized treatment
OpenEye Scientific and Gaussian collaboration expands quantum chemistry calculations
By IPP Bureau - March 09, 2022
Using Orion, pharmaceutical and biotechnology companies, as well as any industrial researcher who wishes to perform electronic structure calculations, can gain access to elastic and flexible computational resources in the Cloud
Alvotech settles with AbbVie to secure US rights to Humira biosimilar
By IPP Bureau - March 09, 2022
Alvotech expects AVT02 (adalimumab) will be marketed in the U.S., subject to regulatory approval, on July 1, 2023
Dr. Andreas Amrein joins Advanced Clinical to lead expansion in APAC, Europe and Canada
By IPP Bureau - March 09, 2022
With over 20 years of international leadership experience, Dr. Amrein has led many teams and organizations across over 30 geographies
Venus Remedies wins WHO GDP certification
By IPP Bureau - March 09, 2022
Internationally accepted pharmaceutical GDP regulations stipulate that distributors of pharmaceutical products and warehouses must align their operations with the specified standards
WHO Global Centre for Traditional Medicine to come up in Jamnagar
By IPP Bureau - March 09, 2022
It will be the first and only global office for traditional medicine in the world
SRL Diagnostics report indicates women neglect routine tests
By IPP Bureau - March 09, 2022
Routine tests undertaken by women dropped by 35% in 2020
Indian Pharma Market growth flat in Feb 2022
By IPP Bureau - March 09, 2022
Price was the key driver for the period
AstraZeneca partners with Indian Society of Nephrology to promote kidney health
By IPP Bureau - March 09, 2022
Under this year’s theme of ‘Kidney Health For All’, ISN along with AstraZeneca aims to generate large scale awareness and educate people about ways to improve kidney health
Novo Nordisk expands research collaboration for biologic medicines
By IPP Bureau - March 09, 2022
This collaboration has resulted in several high-impact scientific publications describing breakthrough inventions, including the SOMA robotic pill, which has subsequently been licensed exclusively to Novo Nordisk for clinical development
Philips mobile cardiac outpatient telemetry detects Atrial Fibrillation early
By IPP Bureau - March 09, 2022
As an initial remote monitoring diagnostic approach, Philips BioTel Heart MCOT detected 4.6 times more patients with atrial fibrillation compared to implantable loop recorder alone
Novartis, Voyager Therapeutics reach license deal for gene therapy vectors to combat neurological diseases
By IPP Bureau - March 09, 2022
Agreement builds on previous Novartis success using emerging technologies to develop first-in-class gene therapies for neurological disorders
